NanoViricides announced licensing agreement with Karveer Meditech to commercialize COVID drugs
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
Quest Diagnostics announced first-of-its-kind post-COVID-19 panels available
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
Tanzania declared an outbreak of Marburg virus disease
On Mar. 21, 2023, the Ministry of Health of the United Republic of Tanzania declared an outbreak of…
Avian Influenza A (H5N1) reported in Cambodia
On Feb. 26, 2023, the Cambodia International Health Regulations (IHR) National Focal Point (NFP) reported one confirmed case…
FDA authorized first OTC at-home test to detect both influenza and COVID-19 viruses
On Feb. 24, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
Researchers document third known case of HIV remission involving stem cell transplant
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
Equatorial Guinea confirmed first-ever Marburg virus disease outbreak
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
Bird flu has begun to spread in mammals
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Vaccine
BD received FDA EUA for COVID-19, influenza A/B, RSV combination test
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
USDA-ARS scientists announded developing new tests, new ways to track COVID In wild and domestic animals
On Feb. 7, 2023, the U.S. Department of Agricultureﾒs Research Service announced that it was implementing a $300…
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
Uganda declared end of Ebola disease outbreak
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
Single booster dose with updated bivalent COVID-19 vaccine provides broad protection against COVID-19 including Omicron variant
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
United Nations reported that a child or youth died once every 4.4 seconds in 2021
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
BD, CerTest Biotec announced Emergency Use Authorization for Mpox diagnostic test
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
NIH study linked specific outdoor air pollutants to asthma attacks in urban children
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
Study revealed that duration of exposure to COVID-19 plays major role in risk of catching the virus
On Dec. 20, 2022, the University of Oxford announced study results using data from 7 million people notified…
Oxford Ebola vaccine manufactured and shipped in record time by Serum Institute of India
On Dec. 15, 2022, the University of Oxford Oxfordﾒs Ebola vaccine candidate has been shipped to Uganda, just…
Ebola vaccine regimens safe, immunogenic in adults and children
On Dec. 14, 2022, the National Institutes of Health announced that two randomized, placebo-controlled trials evaluating three Ebola…
Moderna received FDA EUA for Omicron-targeting bivalent COVID-19 booster vaccine in children 6 months through 5 years of age
On Dec. 8, 2022, Moderna announced it had received emergency use authorization from the U.S. Food and Drug…
Biotechnology | COVID-19 | Therapeutics | Vaccine | WHO
Novavax Nuvaxovid COVID-19 vaccine approved in Canada for use as a primary series in adolescents
On Dec. 7, 2022, Novavax announced that Health Canada had approved a supplement to a New Drug Submission…
FDA accepted for Priority Review the BLA for Pfizerﾒs Respiratory Syncytial Virus Vaccine candidate for prevention of RSV disease in older adults
On Dec. 7, 2022, Pfizer announced that the U.S. Food and Drug Administration (FDA) had accepted for priority…
FDA approved first gene therapy to treat adults with Hemophilia B
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
NIH awarded $12 million for antiviral therapeutic development
On Nov. 21, 2022, the National Institutes of Health awarded more than $12 million to three institutions for…
Novavax Nuvaxovid COVID-19 vaccine received expanded authorization in Canada as a booster in adults
On Nov. 18, 2022, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid (COVID-19 Vaccine (Recombinant…
Roche received U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus
On Nov. 15, 2022, Roche announced that the U.S. Food and Drug Administration had granted Emergency Use Authorization…
University of Missouri study found Monkeypox mutations caused virus to spread rapidly, evade drugs and vaccines
On Nov. 9, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Moderna received Health Canada authorization for second Omicron-targeting bivalent booster
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…